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Abstract 
Background: Tuberculosis is common, can involve various organs of the body and may have diverse presentations. 
Haemophagocytic syndrome is one of the rare presentations of tuberculosis carrying a very high mortality. Early 
detection and institution of anti-tuberculosis medications can be life-saving.
Case presentation: A 23-year-old Bengali man presented with prolonged fever, weight loss, hepatosplenomegaly, 
pancytopenia and altered liver function. He had high erythrocyte sedimentation rate, positive tuberculin test, granu-
loma in liver biopsy, and haemophagocytosis was evidenced by histopathological examination of bone marrow. He 
recovered with anti-tuberculosis therapy.
Conclusion: This case demonstrates that consideration of tuberculosis as an underlying cause of haemophagocytic 
syndrome could be rewarding and life-saving in this rapidly fatal condition.
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Background
Haemophagocytic syndrome (HPS) or haemophagocytic 
lymphangiohistiocytosis (HLH) is an uncommon disor-
der that may present with fever, lymphadenopathy and 
hepatosplenomegaly. Overactive macrophages phago-
cytose erythrocytes, leucocytes, platelets and their pre-
cursors in bone marrow and reticuloendothelial system. 
This syndrome can be primary or secondary. Primary 
HPS is a genetic disorder, occurs in younger age group. 
Secondary HPS may be triggered by viral infections like 
Epstein–Barr virus [1], but bacterial infections like tuber-
culosis (TB) is not uncommon [2–6]. Mortality ranges 
from 41 to 50% and in secondary HPS, delay in diagnosis 
increases mortality [7, 8]. Therefore, early recognition of 
the infective agent and treatment of the cause might be 
life-saving. We report this case to highlight TB as a cause 
of HPS in an adult patient and resolution of the disease 
with anti-TB treatment.
Case presentation
A 23-year-old Bengali man presented with two-month 
history of intermittent fever, oral ulcer, anorexia and 9-kg 
weight loss. He gave history of several episodes of vomit-
ing over five days before hospitalization. He had no other 
significant history of note, except frequent visit to kala-
azar endemic area (Tangail) and sex with commercial sex 
worker two years back. He denied any history of contact 
with known TB cases. For his problems he consulted sev-
eral physicians, underwent various investigations, took 
several courses of broad spectrum antibiotics and one 
course of anti-malarial drug without any benefit. His pre-
admission investigation reports were insignificant except 
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raised alanine aminotransferase (ALT) (142  U/L) and 
ultrasonographic evidence of hepato-splenomegaly.
The patient was very ill [World Health Organization 
(WHO) performance status—Grade 3] and wasted with 
a body mass index (BMI) of 16.7  kg/m2, febrile (temp 
of 102  °F), pulse 112/min, blood pressure 130/80  mm 
Hg. He had an oral ulcer (1  cm  ×  1  cm) on the inner 
side of left cheek with regular margin and whitish sur-
face without any local lymphadenopathy. He had 7-cm 
smooth-surfaced, firm, tender hepatomegaly and 3-cm 
splenomegaly without ascites. Other examination find-
ings including chest, precordium and ocular fundi were 
normal.
His haemoglobin was 10.3 gm/dL, normochromic-nor-
mocytic and erythrocyte sedimentation rate (ESR) was 
150 mm in 1st hour. Hepatic enzymes were raised (ALT 
120  U/L, aspartate aminotransferase (AST) 132  U/L, 
alkaline phosphatase 982  U/L, gamma-glutamyl trans-
ferase (γ-GT) 1097  U/L, bilirubin 1.1  mg/dL) as were 
lactate dehydrogenase (LDH) (1286 U/L) and serum fer-
ritin (3237 ng/mL). Abdominal ultrasonography revealed 
hepatosplenomegaly. Immunochromatography (ICT) for 
kala-azar was negative as were antibody against human 
immunodeficiency virus [anti-HIV (1  +  2)]. Tuberculin 
test revealed 15  mm induration at 72  h. Bone marrow 
examination revealed large histiocytes containing multi-
ple concave nuclei of engulfed myeloid series cells (Fig. 1) 
suggestive of haemophagocytic syndrome. Biopsy from 
oral ulcer did not reveal any granuloma or malignancy. 
Viral serology e.g. IgG for CMV was positive but IgM 
was negative as was Monospot test. Computed tomogra-
phy (CT) of abdomen revealed hepatosplenomegaly with 
multiple isodense lesions in liver and spleen (Fig. 2). Liver 
biopsy revealed non-caseating granuloma with Langhan’s 
giant cell consistent with tuberculosis (Fig.  3). He had 
raised triglyceride levels (2.64 mmol/L).
So, the patient was finally diagnosed as having HPS 
due to disseminated TB. As the patient was seriously ill 
and had raised ALT, modified regime of anti-TB chemo-
therapy (including isoniazide, ethambutol, streptomycin 
and levofloxacin) along with prednisolone 40 mg/day was 
started. He became afebrile on 3rd day of starting anti-
TB drugs but his haematological parameters deterio-
rated (Hb 8.8 gm/dL, total white cell counts 2420/cmm) 
requiring 2 units of blood transfusion. On 2nd week of 
anti-TB therapy, his clinical condition, haematologi-
cal and biochemical parameters improved (Hb 12.1 gm/
dL, total white cell counts 5430/cmm, ALT 87 U/L, AST 
80  U/L, alkaline phosphatase 540  U/L) and we could 
switch him to standard anti-TB drugs and prednisolone 
was discontinued. He was discharged on 4th day of stand-
ard anti-TB medication. The patient received 6-months 
anti-TB medications uneventfully and completely cured 
(Fig. 4).
Discussion
Primary HPS occurs in young patients and usually associ-
ated with genetic disorders [9, 10]. Secondary HPS affects 
people of any age. The causes may be variable ranging 
from infections through autoimmune disorders to malig-
nancy [3]. Overall 3% of all HPS cases are associated with 
TB [11] and Tseng et  al. [12] found that one-fourth of 
infection associated HPS among Taiwanese were due to 
Mycobacterium tuberculosis.
Presenting features of HPS mimics infection, liver dis-
ease, haematological malignancies or even encephalitis. 
A Swedish study reported fever to be the most prominent 
Fig. 1 Bone marrow showing large histiocytes containing multiple 
concave nuclei of engulfed myeloid series cells (white arrow) sugges-
tive of haemophagocytic syndrome
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early feature, followed by hepatomegaly, splenomegaly, 
neurologic symptoms, rashes and lymphadenopathy in 
primary HPS [9]. Laboratory parameters include cytope-
nias, increased ferritin level, morphological evidence of 
haemophagocytosis, etc. The proposed scheme for diag-
nosis of HPS recommends presence of at least five out of 
following nine criteria [13]:
a. fever: peak temperature >38.5 °C for 7 or more days
b. splenomegaly: spleen palpated >3  cm below the left 
costal margin
c. cytopenia involving two or more cell lines: haemo-
globin <9.0 g/dL, or platelet <100,000/µL, or absolute 
neutrophil count <1000/µL
d. hypertryglyceridaemia or hypofibrinogenaemia: fast-
ing triglycerides >2.0 mmol/L, or more than 3 stand-
ard deviations (SD) above the normal value for age, 
or fibrinogen <1.5 g/L, or more than 3 SD below the 
normal value for age
e. haemophagocytosis: demonstrated in bone mar-
row, spleen, or lymph node; no evidence for malig-
nancy
Fig. 2 a, b Computed tomographic (CT) scan of abdomen showing hepatosplenomegaly with multiple isodense lesions in liver and spleen
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f. hepatitis
g. low or absent natural killer cell activity
h. serum ferritin level >500 µg/L (although >3000 µg/L 
is a more realistic cut off to exclude infections and
i. soluble CD25 (sIL-2 receptor) >2400  U/mL (note 
age-related norms).
Our patient had seven out of these nine criteria. Our 
center does not have the capacity to test for natural killer 
cell activity and soluble CD25.
Haemophagocytosis can be demonstrated among biopsy 
samples from bone marrow, liver or spleen, and bone mar-
row is an excellent sample for exhibiting haemophagicyto-
sis associated with TB [2–4, 13]. As TB-associated HPS is 
rare, patients have been treated by different approaches. 
Brastianos et al. [8] in a review of 36 such cases found that 
anti-TB therapy alone showed better survival than combi-
nation of anti-TB drugs and various immunomodulatory 
therapies. In such cases, delay in diagnosis was found to 
be the most important factor for poor outcome [8]. Our 
patient responded well to anti-TB treatment, prednisolone 
was administered only in initial periods.
It should be mentioned that being a high TB-burden 
country, in our clinical practice we encounter many cases 
of disseminated TB even in immunocomtetent individu-
als. Delay in establishing an aetiological diagnosis or 
haematogenous spread may be contributory in this par-
ticular case for such an advanced presentation.
Conclusion
Although associated with multiple conditions, TB should 
always be considered as cause of HPS in countries like 
Bangladesh where TB is endemic. An early diagnosis and 
treatment with appropriate anti-TB drugs is life-saving.
Fig. 3 a, b Liver biopsy showing non-caseating granuloma with 
Langhan’s giant cell (white arrow) consistent with tuberculosis
Fig. 4 Timeline
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